Clinical efficacy of 300IR five-grass pollen sublingual tablet by baseline timothy-specific serum IgE in a US study

被引：0
|
作者：
Cox, L. [1 ]
Casale, T. [2 ]
Creticos, P. [3 ]
Ambroisine, L. [4 ]
Le Gall, M. [4 ]
Melac, M. [4 ]
Zeldin, R. [4 ]
机构：
[1] Nova SE Univ, Sch Osteopath Med, Davie, FL USA
[2] Creighton Univ Allergy & Asthma, Dept Med, Div Allergy & Immunol, Omaha, NE USA
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Stallergenes, Antony, France
来源：
ALLERGY | 2012年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1101
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [1] Assessment of timothy grass-specific serum IgE and IgG4 in a long-term study of 300IR five-grass pollen sublingual tablet
    Malling, H.
    Cadic, V
    Cognet-Sice, J.
    Zeldin, R.
    ALLERGY, 2012, 67 : 418 - 418
  • [2] EFFICACY OF 300IR 5-GRASS POLLEN ALLERGEN SUBLINGUAL IMMUNOTHERAPY (SLIT) TABLETS: SUBGROUP ANALYSIS BY BASELINE TIMOTHY-SPECIFIC IGE
    Cox, L.
    Casale, T.
    Nayak, A.
    Bernstein, D.
    Creticos, P.
    Mekhaldi, S.
    de Beaumont, O.
    Melac, M.
    Montagut, A.
    Zeldin, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A105 - A105
  • [3] Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE
    Cox, Linda S.
    Casale, Thomas B.
    Nayak, Anjuli S.
    Bernstein, David I.
    Creticos, Peter S.
    Ambroisine, Laurence
    Melac, Michel
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 130 (06) : 1327 - +
  • [4] Impact of treatment with 300IR five-grass pollen sublingual tablet on quality of life in grass pollen allergic US adults
    Cox, L.
    Bernstein, D.
    Nayak, A.
    Montagut, A.
    Abiteboul, K.
    Zeldin, R.
    ALLERGY, 2012, 67 : 418 - 419
  • [5] Relationship between disease severity and efficacy of 300IR five-grass pollen sublingual tablets in US adults
    Cox, L.
    Casale, T.
    Ambroisine, L.
    Chaubourt, E.
    Melac, M.
    Zeldin, R.
    ALLERGY, 2012, 67 : 34 - 35
  • [6] Efficacy and safety of a 300IR five-grass pollen SLIT tablet in children and adolescents with grass pollen rhinoconjunctivitis
    Seidenberg, J.
    Agertoft, L.
    Payot, F.
    Juchet, A.
    Emeryk, A.
    M, Melac
    Le Gall, M.
    Wahn, U.
    ALLERGY, 2009, 64 : 146 - 147
  • [7] Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents
    Halken, Susanne
    Agertoft, Lone
    Seidenberg, Juergen
    Bauer, Carl-Peter
    Payot, Francois
    Flora Martin-Munoz, Maria
    Bartkowiak-Emeryk, Malgorzata
    Vereda, Andrea
    Jean-Alphonse, Stephanie
    Melac, Michel
    Le Gall, Martine
    Wahn, Ulrich
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2010, 21 (06) : 970 - 976
  • [8] An assessment of sustained efficacy and safety of a 300IR five-grass pollen sublingual immunotherapy tablet in adults with grass pollen induced allergic rhinoconjunctivitis during a 3-year treatment study
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Le Gall, M.
    Montagut, A.
    Galvain, S.
    Malling, H.
    ALLERGY, 2010, 65 : 172 - 172
  • [9] Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy
    Didier, A.
    Melac, M.
    Montagut, A.
    Lheritier-Barrand, M.
    Tabar, A.
    Worm, M.
    ALLERGY, 2009, 64 (01) : 166 - 171
  • [10] Efficacy and safety of 300IR 5-grass pollen sublingual tablet in allergic patients with and without asthma
    Zeldin, Robert K.
    Montagut, Armelle
    Cognet-Sice, Josiane
    Abiteboul, Kathy
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345